Academic Health Center
Stay Connected
research-and-clinical-trials

Should low risk transplant patients seek care at high risk centers?

Hematopoietic cell transplantation (HCT) is a complex treatment for several hematological disease groups, including many types of cancer.  In a new study published in AJMC, researchers found that low risk HCT patients have had similar survival outcomes irrespective of whether they underwent transplant at higher- or lower-risk centers, even when they adjusted for sociodemographics.

The research conducted by University of Minnesota health policy experts Drs. Schelomo Marmor in the Department of Surgery, with James W. Begun, Jean Abraham and Beth A. Virnig, in the Department of Health Policy and Management. The research group wanted to investigate if facilities that developed an expertise with high risk HCT patients influenced their ability to treat lower risk HCT patients.

Read more
research-and-clinical-trials

Does accreditation impact centers of hematopoietic cell transplantation (HCT)?

There are two hematopoietic cell transplantation (HCT) center-accrediting organizations in the nation, the Foundation for the Accreditation of Cellular Therapy (FACT) and core Clinical Trial Network certification (CTN).

In a recent study conducted by Schelomo Marmor, PhD, M.P.H., from University of Minnesota Department of Surgery, Marmor assessed if these accreditations improved clinical care and survival for HCT, a complex treatment viable for several hematological disease groups.

Read more
in-the-news

In The News: Kersey remembered as bone marrow transplant pioneer

When John Kersey was honored Tuesday night at the University of Minnesota, those in attendance remembered one thing in particular about the late doctor — his pioneering spirit.

David Stahl, who Kersey gave the first bone-marrow transplant in the world in 1975, credited Kersey with saving his life. At the time of treatment, Stahl had been suffering from malignant lymphoma.

“If it wasn’t for Dr. Kersey, I wouldn’t be here,” Stahl told the Star Tribune. “He was the one who said, ‘This is your one option. Let’s try this.’ Other people could have said, ‘We have no help for you.’ ”

Read more
in-the-news

In the News: Twin Cities man undergoes successful and rare third organ transplant at U of M

Otteau Christiansen’s leukemia was already in an advanced phase when he received a bone marrow transplant in 1981. Nobody had ever survived the operation so late into treatment, but Christiansen is living proof that the odds can be overcome.

Read more
expert-perspectives

Game Changer: Gabe Loor

April is National Donate Life Month, which urges Americans to become organ donors and potentially play a part in saving a life. Gabe Loor, a cardiovascular and thoracic surgeon at University of Minnesota Medical School, is a key cog in improving the transplantation process by helping to develop more effective surgical methods.

Read more
patient-care

Midwest’s first breathing lung transplant performed at University of Minnesota Medical Center, Fairview

A team of University of Minnesota cardiothoracic transplant experts have performed the Midwest’s first “breathing lung” transplant, an innovative surgical approach that utilizes technology capable of keeping donated lungs warm and breathing during transportation, keeping them healthier prior to transplant.

Video and full story after the jump.

Read more